NeuroMetrix, Inc. (Nasdaq: NURO), , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced that it has received 510(k) clearance for ...
BOCA RATON, Fla, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and ...
Waltham-based medical device company NeuroMetrix has created the SENSUS Pain Management System, a non-invasive device designed to deliver pain relief to chronic pain and diabetes patients, which has ...
Sensus Healthcare, Inc. is working to recover from a tough Q3, 2022. Preliminary Q4 2022 earnings are reigniting interest in Sensus Healthcare. Sensus Healthcare, Inc. products serve both the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback